Coexpression cluster:C2740

Full id: C2740_Mast_acute_small_leukemia_chronic_biphenotypic_adult

Phase1 CAGE Peaks

Hg19::chr3:42888864..42888881,+	p@chr3:42888864..42888881 +
Hg19::chr4:79697338..79697350,+	p10@BMP2K
Hg19::chr4:79697376..79697386,+	p9@BMP2K
Hg19::chrX:155227410..155227421,+	p4@IL9R

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0004919	interleukin-9 receptor activity	0.00176616036736136
GO:0019983	interleukin-9 binding	0.00176616036736136
GO:0004907	interleukin receptor activity	0.035302931154496
GO:0019965	interleukin binding	0.035302931154496
GO:0004896	hematopoietin/interferon-class (D200-domain) cytokine receptor activity	0.048697238500048
GO:0019838	growth factor binding	0.0498850490643833
GO:0019955	cytokine binding	0.0498850490643833

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n
hematopoietic oligopotent progenitor cell	4.37e-31	165
hematopoietic multipotent progenitor cell	4.37e-31	165
myeloid cell	1.31e-30	112
common myeloid progenitor	1.31e-30	112
hematopoietic stem cell	2.69e-30	172
angioblastic mesenchymal cell	2.69e-30	172
hematopoietic cell	2.52e-27	182
hematopoietic lineage restricted progenitor cell	1.41e-16	124
leukocyte	2.94e-16	140
granulocyte monocyte progenitor cell	2.61e-15	71
myeloid lineage restricted progenitor cell	1.31e-14	70
myeloid leukocyte	7.55e-14	76
nongranular leukocyte	3.35e-12	119
macrophage dendritic cell progenitor	1.12e-11	65
monopoietic cell	1.23e-10	63
monocyte	1.23e-10	63
monoblast	1.23e-10	63
promonocyte	1.23e-10	63
CD14-positive, CD16-negative classical monocyte	2.38e-08	42
mesenchymal cell	7.14e-08	358
connective tissue cell	3.04e-07	365
classical monocyte	4.12e-07	45

Uber Anatomy

Ontology term	p-value	n
hemolymphoid system	5.90e-18	112
hematopoietic system	5.16e-16	102
blood island	5.16e-16	102
immune system	2.07e-15	115
adult organism	1.01e-14	115
bone marrow	1.47e-13	80
bone element	2.42e-13	86
neural tube	7.92e-10	57
neural rod	7.92e-10	57
future spinal cord	7.92e-10	57
neural keel	7.92e-10	57
skeletal element	4.35e-09	101
skeletal system	4.35e-09	101
central nervous system	1.22e-08	82
regional part of brain	1.32e-08	59
brain	2.65e-08	69
future brain	2.65e-08	69
regional part of forebrain	3.34e-08	41
forebrain	3.34e-08	41
future forebrain	3.34e-08	41
telencephalon	5.13e-08	34
anterior neural tube	9.02e-08	42
gray matter	1.58e-07	34
brain grey matter	1.58e-07	34
regional part of telencephalon	1.74e-07	33
cerebral hemisphere	7.06e-07	32

Disease

Ontology term	p-value	n
leukemia	9.13e-21	39
hematologic cancer	1.08e-20	51
immune system cancer	1.08e-20	51
myeloid leukemia	5.28e-17	31

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.